Total Medical devices industry M&A deals worth $4.6bn were announced globally in July 2022, led by’s $3.9bn acquisition of 1Life Healthcare, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 74.4% over the previous month of $2.66bn and a drop of 35.7% when compared with the last 12-month average, which stood at $7.22bn.

Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $4.63bn. At the country level, the US topped the list in terms of deal value at $4.63bn.

In terms of volumes, North America emerged as the top region for Medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in July 2022 was the US with 21 deals, followed by the Canada with three and Republic of Korea (South Korea) with two.

In 2022, as of July, Medical devices M&A deals worth $17.12bn were announced globally, marking an increase of 57.8% year on year.

Medical devices industry M&A deals in July 2022: Top deals

The top five M&A deals accounted for 99.5% of the overall value during July 2022.

The combined value of the top five Medical devices M&A deals stood at $4.62bn, against the overall value of $4.6bn recorded for the month.

The top five Medical devices industry M&A deals of July 2022 tracked by GlobalData were:

1) $3.9bn acquisition deal with 1Life Healthcare

2) The $500m acquisition of OpenEye Scientific Software by Cadence Design Systems

3) Health Sciences Acquisitions2 $158m acquisition deal with Orchestra BioMed

4) The $52.5m acquisition of Palamedrix by SomaLogic

5) Inotiv $11m acquisition deal with Protypia